New York University Cancer Center

New York, New York 10016

0 studies enrolling now · 6 studies all time

What they study most

Advanced Cancer, Breast Cancer, EGFR Gene Mutation, Melanoma, Mesothelioma, Metastatic Cancer, Non Small Cell Lung Cancer, Pancreatic Cancer, Prostate Cancer

Studies at this site

• Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer — Stopped early
• Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer — Completed
• Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer — Stopped early
• Abraxane and Temodar Plus Genasense in Advanced Melanoma — Status unconfirmed
• An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma — Status unconfirmed